BeauBeau - I agree with some of your points and disagree

New Post Public Reply Private Reply Replies (2) Message Board
EliteYoda BeauBeau #10541

BeauBeau - I agree with some of your points and disagree with others.

I do not agree that others should follow my "lead" as I actually do not desire to "lead" the board in any certain direction. My hope is simply that the board can remain a fair, honest and open place for discussion about RFMK but also keeping out obvious agendas whether they be for pumping or for bashing purposes. I think I know what you mean though, as far as others adopting the attitude of fairness, I agree, it's important to have an open mind and see both the good and the dark sides.

I totally agree that as the O/S increases, there is no doubt that the float grows larger over time as well and that in turn makes it much more difficult for the PPS to change in value using the same amount of volume in the past. However, we cannot disregard the possibility of a greater number of shares getting traded daily as the float grows so the PPS and volume ratio may wind up staying roughly in proportion over time, but also maybe not. I think it all depends on the investor exposure the company gets as the story unfolds. If a greater and greater number of investors learn about the RFMK story and become interested and invest/trade then that would in some degree mitigate the growing size of the float. However it is also possible that as the float grows, the investor interest levels remain stagnant and then more and more as time goes on a situation develops wherein there are so many shares in the float just sitting and not trading hands frequently and so a relatively small subset of shares can move the PPS dramatically no matter what puny shares are trading hands among the day traders, etc.

I think it's important to keep the dilution in perspective. The O/S has just about doubled over the last year with Allinder being the CEO. However, there have also been some corporate accomplishments, like launching the CannaCig/Cumulus products and getting out of "debt". Also important it is to keep the two Ironridge financing deals seperate. The first one to get out of "debt" was in fact dilutive and we still do not know how dilutive it could wind up being because Ironridge as far as we know continues to hold a 10% stake and churning their shares all the while getting newly issued shares in order to get their $700k original financing back. Without an audited 10K we can only speculate as to how far along they are in completing that arrangement (how much more dilution of the O/S). Now as for the second part of the deal, it is for $50k/month and all we know so far about that is that Ironridge got 150 pref shares for almost two years worth of this alleged $50k/month which has supposedly started this month (not sure). In other words, I think it is a fallacy to make statements which suggest that Ironridge must go into the market and dump a new traunche of newly issued shares each month in compensation for their $50k/month. That would be mixing the two parts of the deal which IMO is improper. Also another complication is that should the PPS move much much higher during which Ironridge still holds a 10% stake, they could conceivably sell a portion or all of their holdings for much greater sums of money which would not require any more shares to be issued or maybe lessen the number of shares. I would not call it "Toxic Financing" just yet, the game is not over IMO and there are still moves to be made on the board. I would agree though that PAST dilutive financing like the 504D shares to Fairhills and anything BEFORE Allinder was in fact "toxic" because obviously whatever deals those were did nothing for the company and hence only diluted shareholders with nothing in return.

 I agree that the pace of the business plan could be quicker and we have waited too long for many things, most notably the audit and 10K filing as well as the uplist. I have said that for many months. Then again, from a larger perspective, coming into a new CEO position and right away getting financing, Cheryl Shuman, new products launched, affiliates and distributors lined up in just under a year I think is rather impressive. I also rather like the idea that Ironridge is a long term financier and not a short term share dumper like Fairhills Capital (of whom has a SEC litigation against them and is likely the cause of the DTC "chill").

I totally agree that the CEO has over-promised and under-delivered in regards to the audit, 10K filing and uplisting. He made promises of "weeks, not months" back in mid Aug 2012 and there is one more week left in Feb 2013, so that much is obvious. Though there have been quarterly filings made to the OTC markets site, so I think at least shareholders have that much which is good.

I disagree with the notion that the CEO's background is in any way shape or form telling for his performance or future performance in the role of CEO. He was a stock promoter and he promoted many stocks, some of which were less than reputable and turned out to be failures or as they say, "stinky pinkies". But this is not the fault of a promoter, they just do their job and promote the stock. It's like a QA job though, if everything is going right then no one ever congradulates or cares about what is going on or how hard the tester has worked over long periods of time but when the one time that things do go bad then everyone is quick to blame the QA person for the failures and its pitchfork and torches time.

I agree that for RFMK, all the talk in the world means nothing, in the end the company will either perform well or not. The way they peform to build shareholder value is by attaining decent sales and revenues, but that takes time for and development stage business. Performance must be judged on a particular scale when measuring a micro cap start up pinky with very little funds to get business started. We all know that while they are attempting to ramp up the business there is going to be massive dilution and delays from projected business goals. It's easy to over criticize IMO. For me personally, I give more leeway to management as far as developing the business, new products, timing of sales, revenue growth, etc but as a shareholder things I demand ASAP and are requirements not nice-to-haves are FILINGS and completing this audit and filing the 10K would go VERY FAR in this regard. I guess we shall see. I think your complaints are not unfounded but also rather typical of really any pinky start up. Actually I feel pretty good about RFMK because they actually have a product that I can order, receive in the mail and actually use. Most pinkies do not even have a product so IMO RFMK is on a decently good path. Time will tell.

GLTY

$RFMK

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 5

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 6

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 5

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 9

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 5

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 10

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading

Top 5 Most Recently Viewed Articles

Saia Inc. Celebrates Employees' Dedication to Workplace Safety

Updated Category News Views 180

Celebrating Saia’s Commitment to Safety Saia Inc. (NASDAQ: SAIA) is thrilled to acknowledge the extraordinary efforts of nearly 8,000 employees, including dockworkers, mechanics, city drivers, and line drivers, who recently achieved a significant safety milestone. This recognition speaks volumes about the company's unwavering dedication to cultivating a safe work...

Continue Reading
Rhythm Pharmaceuticals Proceeds with Upsized Stock Offering

Updated Category News Views 171

Rhythm Pharmaceuticals Moves Forward with Significant Stock Offering Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) is making headlines with its recent announcement regarding a sizable public offering aimed at strengthening its financial foundation. The Boston-based biopharmaceutical company, which specializes in treatments for rare neuroendocrine diseases, has priced an...

Continue Reading
Eli Lilly's FDA Approval of Omvoh Marks a Pivotal Moment

Updated Category News Views 374

FDA Grants Approval for Eli Lilly's Omvoh in Crohn's Disease Eli Lilly and Company (NYSE: LLY), a leading pharmaceutical firm with remarkable market strength, has achieved a milestone with the FDA's endorsement of Omvoh (mirikizumab-mrkz) for treating adults dealing with moderately to severely active Crohn's disease. This approval follows the earlier sanction for...

Continue Reading
Key Share Capital and Voting Rights Details of VINCI Group

Updated Category News Views 136

Understanding VINCI Group's Share Capital VINCI Group is a prominent French public limited company, known for its extensive involvement in construction and concessions globally. It's essential for investors to stay informed about the company's capital structure and voting rights as of a specific date. Current Capital Structure The share capital of VINCI Group is...

Continue Reading
Kaspi.kz Set to Reveal Its 2024 Financial Performance Soon

Updated Category News Views 292

Kaspi.kz Announces Upcoming Financial Results for 2024 Kaspi.kz (NASDAQ: KSPI) is gearing up to unveil its financial results reflecting the company's performance for the fourth quarter and the entire year of 2024. This eagerly anticipated announcement will take place on a Monday, a fitting choice for stakeholders looking for a fresh start to the week with new insights...

Continue Reading